文章摘要
周雅馨,李红霞,蔡 鑫,符向辉,张 葵,朱 平,吴振彪.白细胞介素33通过促进上皮细胞黏附分子表达参与干燥综合征发病[J].,2021,(10):1824-1828
白细胞介素33通过促进上皮细胞黏附分子表达参与干燥综合征发病
Interleukin-33 Involves in Pathogenesis of Sjögren's Syndrome through Promoting Epithelial Cell Adhesion Molecule Expression
投稿时间:2020-09-23  修订日期:2020-10-17
DOI:10.13241/j.cnki.pmb.2021.10.005
中文关键词: 干燥综合征  白细胞介素33  上皮细胞黏附分子  涎腺上皮细胞
英文关键词: Sjögren's syndrome  Interleukin-33  Epithelial cell adhesion molecule  Salivary gland epithelial cell
基金项目:陕西省科技统筹创新工程计划项目(2016KTCL03-03)
作者单位E-mail
周雅馨 中国人民解放军空军军医大学第一附属医院临床免疫科 全军风湿免疫专科研究所 陕西 西安 710032 immuZhouYaxin@outlook.com 
李红霞 中国人民解放军空军军医大学第一附属医院临床免疫科 全军风湿免疫专科研究所 陕西 西安 710032  
蔡 鑫 中国人民解放军空军军医大学第一附属医院临床免疫科 全军风湿免疫专科研究所 陕西 西安 710032  
符向辉 中国人民解放军空军军医大学第一附属医院临床免疫科 全军风湿免疫专科研究所 陕西 西安 710032  
张 葵 中国人民解放军空军军医大学第一附属医院临床免疫科 全军风湿免疫专科研究所 陕西 西安 710032  
朱 平 中国人民解放军空军军医大学第一附属医院临床免疫科 全军风湿免疫专科研究所 陕西 西安 710032  
吴振彪 中国人民解放军空军军医大学第一附属医院临床免疫科 全军风湿免疫专科研究所 陕西 西安 710032  
摘要点击次数: 797
全文下载次数: 491
中文摘要:
      摘要 目的:探讨白细胞介素(Interleukin-33,IL-33)可能通过调控上皮细胞黏附分子(Epithelial cell adhesion molecule, EpCAM)表达参与干燥综合征(Sj?gren's syndrome, SS)发病的作用机制。方法:收集因SS诊断需要行唇腺活检术的患者血清和唇腺组织标本及相关临床资料,根据2016年ACR-EULAR SS分类诊断标准将患者分为SS组和非SS组,选取性别、年龄匹配的21例SS患者和21例非SS患者,利用多重检测流式试剂盒(人炎症因子组合1)检测血清中IL-33水平并用t检验比较SS患者组与非SS患者组、抗SSA抗体阳性与阴性组以及唇腺病理阳性与阴性组之间IL-33水平的差异。对唇腺组织石蜡切片进行IL-33免疫组织化学染色,用流式细胞术检测新鲜唇腺组织中上皮细胞EpCAM表达水平并与血清IL-33水平进行相关性分析。结果:SS患者组IL-33水平为(1736±590.1,n=21, pg/mL),显著高于非SS患者组(306.8±120.3, n=21, pg/mL)(t=2.373,P=0.027);唇腺病理阳性组即灶性血清IL-33水平(489.8±170, n=27, pg/mL)高于病理阴性组(1978±793.1, n=15, pg/mL),2组之间有统计学差异(t=2.368,P=0.023);而抗SSA抗体阳性组与阴性组之间无明显差异(P>0.05)。免疫组化染色结果提示SS患者唇腺组织上皮细胞IL-33表达相较于非SS患者上升,且血清IL-33水平与唇腺上皮细胞EpCAM的表达呈中等强度正相关(r=0.4915,P=0.0009,95%CI 0.2205-0.692)。结论:IL-33是与SS密切相关的炎症因子,IL-33可能通过促进唾液腺上皮细胞EpCAM的表达参与SS发病。
英文摘要:
      ABSTRACT Objective: To investigate the role of interleukin 33 (IL-33) in the pathogenesis of Sj?gren's syndrome (SS) by regulating the expression of epithelial cell adhesion molecule (EpCAM). Methods: Serum and labial gland tissue samples, as well as clinical data of patients who needed biopsy of labial gland for SS diagnosis were collected. According to the 2016 ACR-EULAR classification criteria of SS, the patients were divided into SS group and non SS group, and the 21 SS patients and 21 non-SS patients were gender and age matched. The serum IL-33 level was detected by Multi-Analyte Flow Assay Kit(Human Inflammation Panel 1). The difference of IL-33 level between SS group and non SS group, anti SSA antibody positive and negative group and labial gland pathology positive and negative group was compared by t test. Immunohistochemical staining of IL-33 was performed on paraffin section of labial gland tissue. The expression of EpCAM in epithelial cells of fresh labial gland tissues was detected by flow cytometry, and the correlation between EpCAM expression and serum IL-33 level was conducted by pearson correlation analysis. Results: The level of IL-33 in SS group was (1736±590.1, n=21, pg/mL), which was significantly higher than that in non SS group (306.8±120.3 n=21, pg/mL) (t=2.373, P=0.027); The level of IL-33 in the pathological positive group (489.8±170, n=27, pg/mL) was higher than that in the pathological negative group (1978±793.1, pg/mL),(t=2.368, P=0.023); But there was no significant difference between the anti-SSA positive group and negative group(P>0.05). The immunohistochemical staining of IL-33 in labial gland epithelial cells of SS patients was more intense than that of non SS patients. Besides, the serum level of IL-33 was positively correlated with the expression of EpCAM (r=0.4915, P=0.0009, 95% CI 0.2205-0.692). Conclusion: IL-33 is a kind of inflammatory cytokine closely related to SS. IL-33 might involve in the pathogenesis of SS through promoting the expression of EpCAM in salivary gland epithelial cells.
查看全文   查看/发表评论  下载PDF阅读器
关闭